[1]
2025. Evaluation of the Efficacy of Second-Line Therapy for Metastatic Gastric Cancer in Real Clinical Practice - the Results of a Multicenter Retrospective Study: Experience of Moscow Oncology Service. Voprosy onkologii. 70, 6 (Jan. 2025), 1189–1198. DOI:https://doi.org/10.37469/0507-3758-2024-70-6-1189-1198.